Surprisingly, no mutations were detected in Idh1, Idh2 and Braf genes that matched to orthologous hot spot mutations in human gliomas and no mutations were observed in spontaneous gliomas (0/4, data not presented). This evidence concerns the gene BRAF and central nervous system cancer.